Ningbo Zhenlei Chemical Co., Ltd. is located in Ningbo, Zhejiang Province,the company's main business includes R & D, production and sales of APIs and intermediates, contract R & D and contract manufacturing,The company has a professional, knowledgeable, young and high-quality staff,and including 3 doctors, 2 masters, a large number of experienced outstanding scientific research workers.
Contract Manufacturing,Perform New Product Development Focus On Pyridine Derivates,Scale Up From Grams To Commercial, Process Optimization,Impurities Manufacture
Green Oxidation,High-Pressure Hydrogenation, C-N Coupling Reaction, C-C Coupling Reaction, Fluorination
Our company specializes in R&D, production and market. The main products are pyridine-3-sulfonyl chloride, sitagliptin phosphate, tofacitinib citrate, perindopril t-butylamine salt ， Cinacalcet hydrochloride and other raw materials and intermediates. In the global pharmaceutical and biochemistry fields, we have rich and excellent network marketing methods and experience, and own strong R&D technical team.VIEW MORE
The main products are Pyridine-3-sulfonyl chloride ,:(2S,3aS,7aS)-Octahydro-1H-indole-2-carboxylic Acid, 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride
The main products are 1-Amino anthraquinone,DIETHYL ACETAMIDOMALONATE-2-13C,Bis(4-hydroxyphenyl) Sulfone,Bromaminic acid,Tetrachlorophthalic anhydride,2-Nitro-p-cresol.
The main products are Methoxyammonium chloride,2-Fluoro-N-methylaniline,3-Methyl-2-nitrobenzoic acid,3,4-Difluorobenzonitrile,2-Fluoroaniline,2-Chloronicotinic acid
The main products are Thiamine hydrochloride,Thiamine nitrate,vitamine (powder/oil),biotin,D-(+)-Pantothenic acid calcium salt.
The main products are TAK 438,sitagliptin phosphate,
Cinacalcet hydrochloride，Tofacitinib citrate,Perindopril erbumine,Rasagiline mesylate,Empagliflozin,
Basic chemical products
The main products are Sodium methanolate,Sodium borohydride,Malonic acid, Bromobenzene.
After combing, we found that in the list of the top 2000, 54 companies in the pharmaceutical industry are among them, accounting for 2.7% of the total. Unsurprisingly, Johnson & Johnson topped the list with a market cap of $275.7 billion, while it ranked 34th
Lung cancer, leukemia and other fields broke foreign monopolies, and the listing of domestic small molecule targeted drugs promoted the price reduction of foreign drugs in China by more than 50%... The major national scientific and technological achievements include not only 4G mobile communication and Beidou satellite navigation, but also biomedical technology innovations closely related to the health of the people.
In order to ensure the quality of non-clinical evaluation research of drugs and protect public use, the State Food and Drug Administration recently issued the newly revised "Good Management Practice for Non-clinical Research of Drugs" (Order No. 34 of the State Food and Drug Administration) (hereinafter referred to as the "Specification")
In order to implement the requirements of the General Office of the CPC Central Committee and the General Office of the State Council on Deepening the Reform of the Review and Approval System and Encouraging the Innovation of Drugs and Devices, the CFDA organized and drafted the Announcement on Adjusting the Review and Approval of Drug Clinical Trials (Draft for Comments), which is now open for comments and suggestions.